Don’t lose sight of M. hyo while battling other swine pathogens
Sep 22, 2021Susan Spiegel
TOOLBOX, Issue 1: An interview with
Lucina Galina Pantoja, DVM, PhD,
Director, Swine Technical Services,
Zoetis
Herd-status classification is first step to Mycoplasma control
Sep 08, 2021Susan Spiegel
By Lucina Galina Pantoja, DVM, PhD, Director, US Pork Technical Services, Zoetis
Pharmacology explains efficacy of Draxxin® for SRD
Aug 04, 2021Susan Spiegel
DISCOVERIES, Issue 27: Pharmacologic research demonstrating how Draxxin® (tulathromycin) injection behaves in the pig explains why this antimicrobial remains a valuable treatment for swine...
Long duration of antibiotic helps improve clinical outcome after APP challenge
Jun 15, 2021Susan Spiegel
DISCOVERIES, Issue 10: Pigs treated with one intramuscular dose of Draxxin® (tulathromycin) and then challenged with a virulent strain of APP had significantly reduced mortality and lung lesions...
Field studies demonstrate safety of Fostera® Gold PCV MH vaccine
Jun 09, 2021Susan Spiegel
DISCOVERIES, Issue 5: Fostera® Gold PCV MH, the inactivated vaccine from Zoetis developed to provide the broadest protection available against porcine circovirus type 2 (PCV2), has been demonstrated...
One dose of Draxxin® at weaning for SRD yields multiple benefit
Apr 14, 2021Susan Spiegel
DISCOVERIES, Issue 13: Pigs from herds with a natural outbreak of swine respiratory disease (SRD) had significantly better outcomes when they received just one injection of Draxxin® (tulathromycin)...
Antimicrobial’s unique attributes explain efficacy against key SRD pathogens
Mar 30, 2021Susan Spiegel
DISCOVERIES, Issue 12: The efficacy of Draxxin® (tulathromycin) against key swine respiratory disease (SRD) pathogens is largely due to the antimicrobial’s ability to reach and sustain high...
Chimera technology offers better path to protection for PCV2
Apr 27, 2020Susan Spiegel
DISCOVERIES, Issue 6: When PCV2 first became a problem in US swine herds, scientists looked at taking the immunogenic capsid gene from PCV2 and cloning it into the backbone of nonpathogenic PCV type...
M. hyo treatment with Draxxin® plays important role in SRD management
Mar 02, 2019Susan Spiegel
DISCOVERIES, Issue 14: Pigs treated for Mycoplasma hyopneumoniae (M. hyo) with a single dose of the injectable antimicrobial Draxxin® (tulathromycin) had significantly better average daily gain and...
Five steps to better Mycoplasma hyopneumoniae control
Oct 17, 2018PGT Editor
For pig producers and veterinarians, the health and economic impact of Mycoplasma hyopneumoniae is clear. In the US, enzootic pneumonia caused by M. hyo is considered one of the “big three”...
Pigs vaccinated with Fostera®PCV MH equally protected, weighed nearly 8 pounds more in large comparison trial
Mar 21, 2018Susan Spiegel
DISCOVERIES, Issue 1: Pigs vaccinated with Fostera® PCV MH were equally protected against porcine circovirus (PCV) type 2d as well as Mycoplasma hyopneumoniae (M. hyo) and weighed 7.78 pounds more...
M. hyo: Control or elimination?
Jun 05, 2017Susan Spiegel
Effective control of Mycoplasma hyopneumoniae (M. hyo) has to start in the breeding herd to prevent problems with the disease in finishers, according to Lucina Galina, DVM, director of technical...
Proposed classification system to improve M. hyo control tested in commercial setting
May 19, 2017Susan Spiegel
By Lucina Galina Pantoja, DVM, PhD, Director, swine technical services, Zoetis
